Glucagon-like peptide-1 receptor agonist (GLP-1RA) is a widely used drug for treatment of diabetes mellitus type 2 (T2DM). It is especially effective for patients with metabolic syndrome such as obesity and hyperlipemia. At present, most GLP-1RA administration methods in the world are subcutaneous injection. Oral semaglutide is the first approved oral GLP-1RA daily preparation, which is formulated with the absorption enhancer N-[8-(2-hydroxyphenylmethyl) amino] salcaprozate sodium (SNAC). Oral semaglutide overcome the problem of peptide drug absorption in acidic gastric fluid. When oral smeiglutide is used alone or in combination with other hypoglycemic agents, it can play a good role in controlling blood glucose, reducing body weight and systolic blood pressure, and is well tolerated, and its safety is consistent with that of GLP- 1RA injection. This article reviewed the recent research progress on oral GLP-1RA in the treatment of T2DM, in order to provide clinical reference for clinic.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |